ClinicalTrials.gov
public full text
Public Domain
Haploidentical Hematopoietic Stem Cell Transplantation
The study is designed as a Pilot/Phase 1 trial of reduced intensity Haploidentical HSCT in patients with sickle cell disease and thalassemia. The purpose of the study is to assess the safety and toxicity of reduced intensity conditioning haploidentical hematopoietic stem cell transplantation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Severe Sickle Cell Disease#814019
- HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity#1230666
- Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation#892536
- High Dose Vitamin D Replacement in Patients Undergoing Hematopoietic Stem Cell Transplantation#1163540
- Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation#828559
Record · ID 1407945
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive